13
Sep
Collaborative Agreement
Comments
Physiomics Plc (AIM: PYC), the Oxford, UK based systems biology company, is pleased to announce that it has signed a collaborative agreement (“Agreement”) with a wholly owned subsidiary of ValiRx plc (AIM: VAL), ValiPharma Limited, a life science company with a focus on cancer diagnostics and therapeutics for personalized medicine, relating to the further development and accelerated progress of VAL201, ValiPharma’s anti-cancer compound.